The Okyanos education center on stem cell therapy is intended to provide patients and others interested with basic, understandable information on the history, science and uses of stem cells and other related subjects. The cardiac stem cell therapy field is advancing as a result of accelerated research into the use of adult stem cells and clinical trials.
Cell therapy that utilizes adult stem cells from the patient’s own body promises to be the next evolution in medicine based on its safety profile, regenerative benefits, repair potential and wide applicability.
Stem cell research began in the 1800′s. In 2001, researchers discovered that fat tissue contains the most abundant source of stem cells in the body. This advance is what has made Okyanos cell therapy possible.
Both the European Union and United States have rigorous standards to ensure the quality and safety of medical devices and drugs. While EU approval is typically faster than FDA approval, research has shown that the EU approval process does not sacrifice safety for speed.
Coronary Artery Disease is caused by an obstruction of the arteries. At a certain point, standard treatment is no longer appropriate for some patients. In these cases, cardiac cell therapy is showing great promise.